Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03FA03	MODODOM	G	Domperidone - 10mg	10mg	Tablet, film coated	147,823 L.L
A03FA03	MOTILAT	G	Domperidone - 10mg	10mg	Tablet	221,734 L.L
A03FA03	NAUZEX	G	Domperidone - 10mg	10mg	Tablet	258,530 L.L
A03FA03	NOVADOM	G	Domperidone - 10mg	10mg	Tablet	278,175 L.L
A03FA03	PROKININ	G	Domperidone - 10mg	10mg	Tablet, film coated	221,734 L.L
A03FA03	MOTILIUM ORAL	B	Domperidone - 5mg/5ml	5mg/5ml	Suspension	377,620 L.L
A03FA03	DOMIDONE CHAPHA SUGAR FREE	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	319,963 L.L
A03FA03	FARCOTILIUM	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	115,570 L.L
A03FA03	MOTIDOL ODT	G	Domperidone - 10mg	10mg	Tablet, orodispersible	259,810 L.L
A03FA07	GANATON	B	Itopride Hydrochloride - 50mg	50mg	Tablet	1,119,421 L.L
A03FA07	GANATON	B	Itopride Hydrochloride - 50mg	50mg	Tablet	357,462 L.L
A03FA07	GAROPRIDE	G	Itopride Hydrochloride - 50mg	50mg	Tablet, film coated	213,671 L.L
A03FA08	CINITREX	G	Cinitapride - 1mg	1mg	Tablet	636,981 L.L
A03FA09	MOSAR	B	Mosapride citrate - 5mg	5mg	Tablet, coated	798,242 L.L
A04AA01	ZOFRAN	B	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	6,329,648 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
A04AA01	NAUSETRON	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, scored	1,023,880 L.L
A04AA01	NOZENTRIX	G	Ondansetron - 8mg	8mg	Tablet, film coated	1,151,865 L.L
A04AA01	ONDAKEY	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	4,489,778 L.L
A04AA01	ONDANSETRON BIOGARAN	G	Ondansetron - 8mg	8mg	Tablet, coated	1,307,559 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	748,520 L.L
A04AA01	ZOFRAN INJECTION	B	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	7,280,806 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	880,217 L.L
A04AA01	ONDANSETRON HIKMA	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	2,228,091 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron - 4mg/2ml	4mg/2ml	Injectable solution	978,317 L.L
A04AA01	ONDANSETRON RENAUDIN	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	1,791,342 L.L
A04AA01	ONDANSETRON VIANEX	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	197,545 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	2,027,858 L.L
A04AA01	ZOFRAN INJECTION	B	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	9,752,244 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	952,784 L.L

...

187